AGP Wire

AGP

FCM Travel Asia has expanded its Japan management team with three senior appointments as it pushes for growth in the market.

AGP

The Business Research Company says the global market for Adstiladrin, a gene therapy for high-risk non-muscle-invasive bladder cancer, is being shaped by rising bladder cancer cases, higher healthcare spending, and broader adoption of precision…

AGP

The Asia Pacific silica sand market is projected to almost double by 2035, driven by construction, glass manufacturing, and industrial growth across China, India and Southeast Asia. Market Research Future forecasts the region will rise from 181.5…

AGP

The Business Research Company says the Ajovy market is set to expand through 2035 as migraine diagnoses rise, preventive treatment gains ground and biologic therapies become more accepted.

AGP

The Business Research Company projects the adrenal cancer diagnostics market will grow from $157.36 billion in 2026 to $206.14 billion by 2030, driven by imaging advances, targeted therapies and broader use of PET-CT scans.

AGP

Syndacast, the Bangkok- and Singapore-based hospitality marketing agency, was named Best Travel & Hospitality Marketing Agency - Asia 2026 by World Business Outlook.

AGP

The acute spinal cord injury market is projected to grow from $7.43 billion in 2026 to $9.4 billion by 2030, according to The Business Research Company.

AGP

The adenosine triphosphate (ATP) assays market is projected to grow at a 12.2% CAGR to $3.88 billion by 2030, according to a new Business Research Company report.

AGP

The Business Research Company says the global Albuked market has long-term growth potential through 2035, driven by rising liver disease cases, ICU demand and interest in safer non-plasma alternatives.

AGP

The Business Research Company says the global Admelog market is set for long-term growth through 2035, driven by rising diabetes cases, expanding biosimilar use and government efforts to contain insulin costs.

AGP

The Business Research Company says the Afstyla market is gaining traction as hemophilia A diagnoses rise and more patients move toward recombinant factor VIII therapies.

AGP

LEPAS is lining up launches in five new European markets, including Denmark, in the first half of 2027 after expanding its global distribution network across Europe, Asia, the Middle East, Africa and Latin America.

AGP

The Business Research Company says Aimovig’s global market is set to expand through 2035, driven by rising migraine diagnoses, broader insurance coverage, and growing use of preventive biologics.

AGP

LEPAS is widening its global distribution network and plans to enter Hungary, along with four other European markets, in the first half of 2027. The Chery Group premium NEV brand has already secured partners across Europe, Asia, the Middle East,…

AGP

The Business Research Company says the Afrezza market is set for stronger growth through 2035, driven by rising diabetes cases, higher healthcare spending and broader acceptance of inhaled insulin.

AGP

The Business Research Company says the global Afrezza market is set for stronger growth through 2035 as diabetes cases rise, healthcare spending increases and inhaled insulin gains wider acceptance.

AGP

The Business Research Company says the Afluria vaccine market is set to expand through 2035, driven by seasonal flu outbreaks, broader vaccination coverage and a growing older population.

AGP

The adeno-associated viral vectors market is projected to climb from $3.17 billion in 2025 to $6.65 billion by 2030 as gene therapy activity expands worldwide.

AGP

The Business Research Company says the adenosine deaminase-severe combined immunodeficiency market will rise from $6.33 billion in 2026 to $8.11 billion by 2030. Growth is expected to be driven by more gene therapy, enzyme replacement and stem…

AGP

RAMEN TECH 2026 opens Oct. 7 across Fukuoka for a five-day startup and co-creation week expected to draw more than 15,000 participants.